Nature’s Sunshine Products (NASDAQ:NATR) Given New $21.00 Price Target at DA Davidson

Nature’s Sunshine Products (NASDAQ:NATR) had its price target cut by investment analysts at DA Davidson from $23.00 to $21.00 in a note issued to investors on Monday, Benzinga reports. The firm presently has a “buy” rating on the stock. DA Davidson’s target price would indicate a potential upside of 78.27% from the company’s previous close.

Nature’s Sunshine Products Price Performance

NASDAQ NATR traded down $0.85 on Monday, reaching $11.78. The company had a trading volume of 185,974 shares, compared to its average volume of 57,806. The firm’s 50 day moving average price is $15.32 and its 200 day moving average price is $17.15. Nature’s Sunshine Products has a 12 month low of $10.81 and a 12 month high of $21.72. The stock has a market capitalization of $220.64 million, a PE ratio of 13.79 and a beta of 0.87. The company has a quick ratio of 1.42, a current ratio of 2.33 and a debt-to-equity ratio of 0.01.

Insider Activity at Nature’s Sunshine Products

In other news, EVP Bryant J. Yates sold 3,068 shares of the stock in a transaction that occurred on Thursday, June 6th. The stock was sold at an average price of $15.30, for a total transaction of $46,940.40. Following the completion of the transaction, the executive vice president now directly owns 98,852 shares in the company, valued at approximately $1,512,435.60. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 4.70% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Nature’s Sunshine Products

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Jacobs Levy Equity Management Inc. lifted its stake in Nature’s Sunshine Products by 1.6% in the first quarter. Jacobs Levy Equity Management Inc. now owns 58,507 shares of the company’s stock worth $1,215,000 after purchasing an additional 927 shares during the last quarter. Lazard Asset Management LLC boosted its holdings in Nature’s Sunshine Products by 16.5% during the 1st quarter. Lazard Asset Management LLC now owns 7,040 shares of the company’s stock valued at $146,000 after acquiring an additional 998 shares during the period. Gladius Capital Management LP grew its position in Nature’s Sunshine Products by 23.9% in the 2nd quarter. Gladius Capital Management LP now owns 6,862 shares of the company’s stock valued at $103,000 after acquiring an additional 1,325 shares during the last quarter. BNP Paribas Financial Markets increased its stake in Nature’s Sunshine Products by 12.7% in the first quarter. BNP Paribas Financial Markets now owns 15,207 shares of the company’s stock worth $316,000 after purchasing an additional 1,715 shares during the period. Finally, Janney Montgomery Scott LLC increased its stake in Nature’s Sunshine Products by 8.9% in the first quarter. Janney Montgomery Scott LLC now owns 25,200 shares of the company’s stock worth $523,000 after purchasing an additional 2,054 shares during the period. 79.40% of the stock is currently owned by hedge funds and other institutional investors.

About Nature’s Sunshine Products

Nature's Sunshine Products, Inc, a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision.